DESIGN AND STATISTICAL EVALUATION OF A MULTIUNIT DELIVERY SYSTEM CONTAINING NISOLDIPINE-SOLUPLUS® SOLID DISPERSION FOR HYPERTENSION CHRONOTHERAPY
DOI:
https://doi.org/10.22159/ijpps.2016v8i10.13442Keywords:
Central composite design, Nil, Design of experiments, Chronotherapy, Fluidized-bed, Dissolution efficiency, Eudragit, JMPAbstract
Objective: To study the mechanism and factors affecting the design of an industrially scalable formulation in a combined drug delivery module containing solid dispersion (SD) multiunit pellets with novel polymer Soluplus® in a modified release system to address chronotherapeutic needs of hypertension therapy.
Methods: Nisoldipine-Soluplus® SD pellet formulations were prepared using the central composite design of experiments (CCD) to study the effect of inert core level and drug to polymer ratio. The solid dispersions were formed on inert pellets surface by fluidized bed coating and characterized by dissolution efficiency and time for 90% drug release. The data was statistically analyzed to develop a response surface for optimum SD formulation in pellets. The SD pellets were characterized by FTIR, DSC and SEM. The optimum formulation of SD coated pellets was further coated with Eudragit S100-L100 polymer mix and characterized for dissolution in multimedia and two-step dissolution for lag time.
Results: A response surface was developed for highest dissolution efficiency (%DE) and least time to release 90% drug (T90). The model was significant, and the role of core pellets was found to be more significant than the drug-polymer ratio. The study of the desirability function indicated that a polymer content of 75% and inert core level to yield 23% net weight gain, provided optimum dissolution enhanced SD pellets. The drug was found to exist in amorphous form. The final capsules containing Eudragit S100-L100 coated delayed release SD pellets showed a lag time of 2 h and a definite pH-gradient towards drug release.
Conclusion: The findings from this study helped to understand the mechanism, design and factors affecting drug release from a delayed release SD system for a poorly soluble drug for potential hypertension chronotherapy.
Downloads
References
Singh A, Worku ZA, Van Den MG. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin Drug Delivery 2011;8:1361–78.
Serajuddin AT. The solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058-66.
Karanth H, Shenoy VS, Murthy RR. Industrially feasible alternative approaches in the manufacture of solid dispersions. AAPS PharmSciTech 2006;7:1-8.
Hardung H, Djuric D, Ali S. Combining HME and solubilization: soluplus®-the solid solution. Drug Dev Technol 2010;3:20–7.
El Maghraby GM, Ahmed AA, Osman AM. Skin delivery of nisoldipine from niosome pro-concentrate. J Appl Pharm Sci 2014;4:112-7.
Heinig R. Clinical pharmacokinetics of nisoldipine coat-core. Clin Pharmacokinet 1998;35:191-208.
Sica DA, Prisant M. Pharmacologic and therapeutic considerations in hypertension therapy with calcium channel blockers: focus on verapamil. J Clin Hypertens 2007;9 Suppl 2:1-22.
Latha K, Uhumwangho MU, Sunil SA, Srikanth MV, Ramana Murthy KV. Chronobiology and chronotherapy of hypertension–a review. Int J Health Res 2010;3:121-31.
Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117-22.
Harrington Jr EC. The desirability function. Ind Qual Control 1995;21:494–8.
Zuo J, Gao Y, Bou-Chacra N, Löbenberg R. Evaluation of the DD solver software applications. BioMed Res Int 2014:1-9. http://dx.doi.org/10.1155/2014/204925
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217-23.
Tiwari R, Agarwal SK, Murthy RSR, Tiwari S. Formulation and evaluation of sustained release extrudes prepared via novel hot melt extrusion technique. J Pharm Innov 2014;9:246–58.
Dokoumetzidis A, Macheras P. A century of dissolution research: from noyes and whitney to the biopharmaceutics classification system. Int J Pharm 2006;321:1-11.
Ho H, Su HL, Tsai T, Sheu MT. The preparation and characterization of solid dispersions on pellets using a fluidized-bed system. Int J Pharm 1996;139:223-9.
Lei Y, Lu Y, Qi J, Nie S, Hu F, Pan W, et al. Solid self-nano-emulsifying cyclosporine-A pellets prepared by fluid-bed coating: preparation, characterization and in vitro re-dispersibility. Int J Nanomed 2011;6:795-805.
Liua J, Caoa F, Zhang C, Ping Q. Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm Sin B 2013;3:263–72.
El Maghraby GM, Elsergany R. Fast disintegrating tablets of nisoldipine for intra-oral administration. Pharm Dev Technol 2014;19:641–50.
Vats SK, Gupta RN, Ramaraju K, Singh R. Systematic optimization of formulation and manufacturing method for preparing a rapid release nisoldipine dosage form. J Chem Pharm Res 2015;7:96-107.
Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm 1996;136:117-39.
Kramer A, Turk S, Vrecer F. Statistical optimization of diclofenac sodium sustained release pellets coated with polymethacrylic films. Int J Pharm 2003;256:43-52.
Watts PJ, Illum L. Colonic drug delivery. Drug Dev Ind Pharm 1997;23:893-913.
Khan MZ, Stedul HP, Kurjaković N. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug releases using Eudragit L100 and Eudragit S100 combinations. Drug Dev Ind Pharm 2000;26:549-54.
Asghar LFA, Chandran S. Multiparticulate formulation approach to colon-specific drug delivery: current perspectives. J Pharm Pharm Sci 2006;9:327-38.
The United States Pharmacopoeial Convention. <711>Dissolution. United States Pharmacopoeia 32nd and National Formulary 27th. The USP Convention, Rockville; 2009.
Published
How to Cite
Issue
Section
